Logo Encompass Health

Encompass Health (EHC) stock: analyst price target and their real reliability

Live quote · data updated Aug 28, 2026
Encompass Health · Health Care · ref. ETF XLV · 62 calls · price $119.57
🔔Price alertsCreate an alert →
What the company does: Encompass Health Corporation operates inpatient rehabilitation hospitals in the United States and Puerto Rico.

📈 Encompass Health (EHC) stock price

$119.57-3.1% over range
Aug 28, 25low $93.83 · high $127.18Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
100% recommend buying · 4 analysts
📊 JPI status : Encompass Health has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →

🎯 EHC price target & analyst consensusprice $120

The price target · all analysts combined (4 targets)
Highest target · 1 firm of 4$155+29.6%
Median target · of 4 targets$147+22.9%
Lowest target · 1 firm of 4$140+17.1%
Current price$119.57
Where these 4 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price 4100% $140 ↔ $155
⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: Truist Securities64% of its targets hit on this sector (109 calls tested). It aims for $150 (+25 %), call made on August 8, 2026, maturing on August 8, 2027 (20 d ago).

The 3 reliable analysts $150+25 %
The 1 other firm $144+20 %
How to read it: the 3 reliable firms are not filtered by optimism — 3 aim above the price, 0 below, hence their $150 median. “The 1 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 4 ratings (last 6 months)
Strong Buy00%
Buy4100%
Hold00%
Sell00%
Strong Sell00%
Go deeper on the analysts
All analysts (the consensus)  ·  vs  ·  the best (those who've been right)
💬 A question about Encompass Health? The JPI assistant answers using our backtest data.

💰 Encompass Health dividend: yield, history & growth › open the full page

0.92%annual yield
That's ~$0.93 per share per year.

📈 Encompass Health fundamentals: valuation, margins & growth › open the full page

P/E 20.2Net margin 10.0 %Revenue growth +9.6 %Fairly valued

Revenue, net income and margin per year

Revenue Net income · hover a bar for details
2022
marg. 6 %
2023
Rev +10%Profit +30%
2024
Rev +12%Profit +29%
2025
Rev +10%Profit +24%

🔎 Detailed analyses

✅ Historical analyst reliability on EHC

Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.

Firm % right i Gain vs sector i Calls i
Mizuho  100% +21.2% 8
Jefferies  100% +15.9% 2
B of A Securities  100% +15.9% 2
Stephens & Co.  91% +23.7% 11
RBC Capital  85% +21.7% 13
Truist Securities  83% +21.2% 12
Barclays  82% +20.4% 11
Raymond James  73% +13.1% 15
Credit Suisse 73% +11.8% 15
BMO Capital  67% +12.8% 3
See the other 3 firms
Deutsche Bank  50% +2.1% 2
Keybanc  60% +7.2% 5
UBS  67% +10.2% 9

📊 What $1,000 invested in Encompass Health would be worth › open the full page

In short — $1,000 invested in Encompass Health 10 years ago would be worth $3,607 today, i.e. +14%/yr on average. Best year: 2024 (+35%), worst: 2021 (-18%). Price performance, excluding dividends.

If I'd invested $1,000 in Encompass Health

InvestmentWorth todayGain
1 years ago$1,009+1%
3 years ago$1,788+79%
5 years ago$1,580+58%
→ See Encompass Health's full return history + gain calculator

Return by year (Encompass Health)

YearReturn$1,000 invested at year start
2026 (YTD)-6%$937 (-6%)
2025+8%$1,009 (+1%)
2024+35%$1,359 (+36%)
→ See Encompass Health's full return history + gain calculator
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.

📰 Recent news on Encompass Health

Loading news…

📋 All analyst calls on EHC

TD Cowen 
Aug 10, 26
▲ Buy · 🎯$140
Price at call : $125.35 — upside +12%
Today : $119.57 — upside +17%
🎯 on EHC : no call matured yet · 📊 on Health : 53.8% · +17.8% (26 calls)
in progress (365j)
matures : Aug 10, 27
UBS 
Aug 8, 26
▲ Buy · 🎯$155
Price at call : $125.81 — upside +23%
Today : $119.57 — upside +30%
🎯 on EHC : 75% (4 calls matureds) · 📊 on Health : 49.6% · +18.1% (119 calls)
in progress (365j)
matures : Aug 8, 27
▲ Buy · 🎯$150
Price at call : $125.23 — upside +20%
Today : $119.57 — upside +25%
🎯 on EHC : 83% (12 calls matureds) · 📊 on Health : 58.7% · +5.8% (109 calls)
in progress (365j)
matures : Aug 7, 27
Barclays 
Aug 6, 26
▲ Overweight · 🎯$144
Price at call : $124.82 — upside +15%
Today : $119.57 — upside +20%
🎯 on EHC : 88% (8 calls matureds) · 📊 on Health : 47.9% · +1.6% (194 calls)
in progress (365j)
matures : Aug 6, 27
TD Cowen 
May 28, 26
▲ Buy · 🎯$125
Price at call : $105.85 — upside +18%
Today : $119.57 — upside +5%
🎯 on EHC : no call matured yet · 📊 on Health : 53.8% · +17.8% (26 calls)
in progress (365j)
matures : May 28, 27
Barclays 
May 5, 26
▲ Overweight · 🎯$140
Price at call : $105.01 — upside +33%
Today : $119.57 — upside +17%
🎯 on EHC : 88% (8 calls matureds) · 📊 on Health : 47.9% · +1.6% (194 calls)
in progress (365j)
matures : May 5, 27
Barclays 
Feb 6, 26
▲ Overweight · 🎯$153
Price at call : $106.16 — upside +44%
Today : $119.57 — upside +28%
🎯 on EHC : 88% (8 calls matureds) · 📊 on Health : 47.9% · +1.6% (194 calls)
in progress (365j)
matures : Feb 6, 27
Barclays 
Oct 30, 25
▲ Overweight · 🎯$150
Price at call : $113.85 — upside +32%
Today : $119.57 — upside +25%
🎯 on EHC : 88% (8 calls matureds) · 📊 on Health : 47.9% · +1.6% (194 calls)
in progress (365j)
matures : Oct 30, 26
See the other 54 calls, newest to oldest
UBS 
Oct 2, 25
▲ Buy · 🎯$150
Price at call : $123.55 — upside +21%
Today : $119.57 — upside +25%
🎯 on EHC : 75% (4 calls matureds) · 📊 on Health : 49.6% · +18.1% (119 calls)
in progress (365j)
matures : Oct 2, 26
Keybanc 
Sep 16, 25
▲ Overweight · 🎯$140
Price at call : $123.81 — upside +13%
Today : $119.57 — upside +17%
🎯 on EHC : 60% (5 calls matureds) · 📊 on Health : 32.6% · -10.5% (43 calls)
in progress (365j)
matures : Sep 16, 26
▲ Buy · 🎯$160
Price at call : $126.8 — upside +26%
Today : $119.57 — upside +34%
🎯 on EHC : no call matured yet · 📊 on Health : 64.8% · +20.2% (105 calls)
in progress (365j)
matures : Sep 10, 26
▲ Buy · 🎯$140
Price at call : $119.65 — upside +17%
Today : $119.57 — upside +17%
Expected +17% · Actual +3% · Reason (≥ +15%) : ✗ No
🎯 on EHC : 83% (12 calls matureds) · 📊 on Health : 58.7% · +5.8% (109 calls)
+3.3%
stock +3% · XLV +25%
matured Aug 14, 26
UBS 
Aug 6, 25
▲ Buy · 🎯$140
Price at call : $116.51 — upside +20%
Today : $119.57 — upside +17%
Expected +20% · Actual +7% · Reason (≥ +15%) : ✗ No
🎯 on EHC : 75% (4 calls matureds) · 📊 on Health : 49.6% · +18.1% (119 calls)
+7.5%
stock +7% · XLV +28%
matured Aug 6, 26
▲ Overweight · 🎯$135
Price at call : $121.54 — upside +11%
Today : $119.57 — upside +13%
Expected +11% · Actual -17% · Reason (≥ +15%) : ✗ No
🎯 on EHC : 91% (11 calls matureds) · 📊 on Health : 64.1% · +10.3% (39 calls)
-16.8%
stock -17% · XLV +14%
matured Jun 5, 26
Keybanc 
May 27, 25
▲ Overweight · 🎯$135
Price at call : $121.01 — upside +12%
Today : $119.57 — upside +13%
Expected +12% · Actual -14% · Reason (≥ +15%) : ✗ No
🎯 on EHC : 60% (5 calls matureds) · 📊 on Health : 32.6% · -10.5% (43 calls)
-13.8%
stock -14% · XLV +13%
matured May 27, 26
UBS 
Apr 28, 25
▲ Buy · 🎯$130
Price at call : $115.91 — upside +12%
Today : $119.57 — upside +9%
Expected +12% · Actual -11% · Reason (≥ +15%) : ✗ No
🎯 on EHC : 75% (4 calls matureds) · 📊 on Health : 49.6% · +18.1% (119 calls)
-11.5%
stock -11% · XLV +3%
matured Apr 28, 26
RBC Capital 
Apr 28, 25
▲ Outperform · 🎯$125
Price at call : $115.91 — upside +8%
Today : $119.57 — upside +5%
Expected +8% · Actual -11% · Reason (≥ +15%) : ✗ No
🎯 on EHC : 86% (7 calls matureds) · 📊 on Health : 49.2% · +7.0% (195 calls)
-11.5%
stock -11% · XLV +3%
matured Apr 28, 26
▲ Buy · 🎯$135
Price at call : $115.91 — upside +16%
Today : $119.57 — upside +13%
Expected +16% · Actual -11% · Reason (≥ +15%) : ✗ No
🎯 on EHC : 83% (12 calls matureds) · 📊 on Health : 58.7% · +5.8% (109 calls)
-11.5%
stock -11% · XLV +3%
matured Apr 28, 26
Keybanc 
Apr 25, 25
▲ Overweight · 🎯$122
Price at call : $115.32 — upside +6%
Today : $119.57 — upside +2%
Expected +6% · Actual -12% · Reason (≥ +15%) : ✗ No
🎯 on EHC : 60% (5 calls matureds) · 📊 on Health : 32.6% · -10.5% (43 calls)
-12.5%
stock -12% · XLV +4%
matured Apr 25, 26
Barclays 
Apr 25, 25
▲ Overweight · 🎯$129
Price at call : $113.37 — upside +14%
Today : $119.57 — upside +8%
Expected +14% · Actual -11% · Reason (≥ +15%) : ✗ No
🎯 on EHC : 88% (8 calls matureds) · 📊 on Health : 47.9% · +1.6% (194 calls)
-11.0%
stock -11% · XLV +4%
matured Apr 25, 26
RBC Capital 
Feb 11, 25
▲ Outperform · 🎯$110
Price at call : $98.03 — upside +12%
Today : $119.57 — upside -8%
Expected +12% · Actual +14% · Reason (≥ +15%) : ✗ No
🎯 on EHC : 86% (7 calls matureds) · 📊 on Health : 49.2% · +7.0% (195 calls)
+14.3%
stock +14% · XLV +7%
matured Feb 11, 26
Keybanc 
Feb 10, 25
▲ Overweight · 🎯$120
Price at call : $98.63 — upside +22%
Today : $119.57 — upside +0%
Expected +22% · Actual +11% · Reason (≥ +15%) : ✗ No
🎯 on EHC : 60% (5 calls matureds) · 📊 on Health : 32.6% · -10.5% (43 calls)
+10.5%
stock +11% · XLV +6%
matured Feb 10, 26
Barclays 
Feb 7, 25
▲ Overweight · 🎯$118
Price at call : $98.63 — upside +20%
Today : $119.57 — upside -1%
Expected +20% · Actual +8% · Reason (≥ +15%) : ✗ No
🎯 on EHC : 88% (8 calls matureds) · 📊 on Health : 47.9% · +1.6% (194 calls)
+7.6%
stock +8% · XLV +7%
matured Feb 7, 26
RBC Capital 
Oct 30, 24
▲ Outperform · 🎯$110
Price at call : $99.46 — upside +11%
Today : $119.57 — upside -8%
Expected +11% · Actual +14% · Reason (≥ +15%) : ✗ No
🎯 on EHC : 86% (7 calls matureds) · 📊 on Health : 49.2% · +7.0% (195 calls)
+14.5%
stock +14% · XLV -2%
matured Oct 30, 25
▲ Buy · 🎯$116
Price at call : $99.46 — upside +17%
Today : $119.57 — upside -3%
Expected +17% · Actual +14% · Reason (≥ +15%) : ✗ No
🎯 on EHC : 83% (12 calls matureds) · 📊 on Health : 58.7% · +5.8% (109 calls)
+14.5%
stock +14% · XLV -2%
matured Oct 30, 25
Barclays 
Oct 29, 24
▲ Overweight · 🎯$116
Price at call : $100 — upside +16%
Today : $119.57 — upside -3%
Expected +16% · Actual +26% · Reason (≥ +15%) : ✓ Yes
🎯 on EHC : 88% (8 calls matureds) · 📊 on Health : 47.9% · +1.6% (194 calls)
+25.6%
stock +26% · XLV -3%
matured Oct 29, 25
Keybanc 
Oct 29, 24
▲ Overweight · 🎯$117
Price at call : $100 — upside +17%
Today : $119.57 — upside -2%
Expected +17% · Actual +26% · Reason (≥ +15%) : ✓ Yes
🎯 on EHC : 60% (5 calls matureds) · 📊 on Health : 32.6% · -10.5% (43 calls)
+25.6%
stock +26% · XLV -3%
matured Oct 29, 25
▲ Buy · 🎯$108
Price at call : $96.33 — upside +12%
Today : $119.57 — upside -10%
Expected +12% · Actual +28% · Reason (≥ +15%) : ✓ Yes
🎯 on EHC : 83% (12 calls matureds) · 📊 on Health : 58.7% · +5.8% (109 calls)
+28.4%
stock +28% · XLV -7%
matured Oct 14, 25
Keybanc 
Oct 11, 24
▲ Overweight · 🎯$115
Price at call : $96.3 — upside +19%
Today : $119.57 — upside -4%
Expected +19% · Actual +26% · Reason (≥ +15%) : ✓ Yes
🎯 on EHC : 60% (5 calls matureds) · 📊 on Health : 32.6% · -10.5% (43 calls)
+26.0%
stock +26% · XLV -8%
matured Oct 11, 25
RBC Capital 
Sep 26, 24
▲ Outperform · 🎯$105
Price at call : $96.01 — upside +9%
Today : $119.57 — upside -12%
Expected +9% · Actual +31% · Reason (≥ +15%) : ✓ Yes
🎯 on EHC : 86% (7 calls matureds) · 📊 on Health : 49.2% · +7.0% (195 calls)
+31.1%
stock +31% · XLV -11%
matured Sep 26, 25
UBS 
Sep 25, 24
▲ Buy · 🎯$110
Price at call : $97.17 — upside +13%
Today : $119.57 — upside -8%
Expected +13% · Actual +30% · Reason (≥ +15%) : ✓ Yes
🎯 on EHC : 75% (4 calls matureds) · 📊 on Health : 49.6% · +18.1% (119 calls)
+30.4%
stock +30% · XLV -12%
matured Sep 25, 25
▲ Buy · 🎯$104
Price at call : $89.3 — upside +16%
Today : $119.57 — upside -13%
Expected +16% · Actual +35% · Reason (≥ +15%) : ✓ Yes
🎯 on EHC : 83% (12 calls matureds) · 📊 on Health : 58.7% · +5.8% (109 calls)
+34.8%
stock +35% · XLV -11%
matured Aug 15, 25
UBS 
Aug 8, 24
▲ Buy · 🎯$100
Price at call : $85.72 — upside +17%
Today : $119.57 — upside -16%
Expected +17% · Actual +37% · Reason (≥ +15%) : ✓ Yes
🎯 on EHC : 75% (4 calls matureds) · 📊 on Health : 49.6% · +18.1% (119 calls)
+37.0%
stock +37% · XLV -13%
matured Aug 8, 25
▲ Overweight · 🎯$105
Price at call : $84.99 — upside +24%
Today : $119.57 — upside -12%
Expected +24% · Actual +37% · Reason (≥ +15%) : ✓ Yes
🎯 on EHC : 91% (11 calls matureds) · 📊 on Health : 64.1% · +10.3% (39 calls)
+37.1%
stock +37% · XLV -12%
matured Aug 6, 25
Barclays 
Aug 6, 24
▲ Overweight · 🎯$109
Price at call : $84.99 — upside +28%
Today : $119.57 — upside -9%
Expected +28% · Actual +37% · Reason (≥ +15%) : ✓ Yes
🎯 on EHC : 88% (8 calls matureds) · 📊 on Health : 47.9% · +1.6% (194 calls)
+37.1%
stock +37% · XLV -12%
matured Aug 6, 25
▲ Buy · 🎯$100
Price at call : $87.14 — upside +15%
Today : $119.57 — upside -16%
Expected +15% · Actual +26% · Reason (≥ +15%) : ✓ Yes
🎯 on EHC : 83% (12 calls matureds) · 📊 on Health : 58.7% · +5.8% (109 calls)
+26.1%
stock +26% · XLV -10%
matured Jul 15, 25
Barclays 
Jul 11, 24
▲ Overweight · 🎯$113
Price at call : $85.9 — upside +32%
Today : $119.57 — upside -5%
Expected +32% · Actual +38% · Reason (≥ +15%) : ✓ Yes
🎯 on EHC : 88% (8 calls matureds) · 📊 on Health : 47.9% · +1.6% (194 calls)
+37.9%
stock +38% · XLV -8%
matured Jul 11, 25
▲ Outperform · 🎯$100
Price at call : $84.77 — upside +18%
Today : $119.57 — upside -16%
Expected +18% · Actual +39% · Reason (≥ +15%) : ✓ Yes
🎯 on EHC : 100% (1 call matured) · 📊 on Health : 54.5% · +10.0% (11 calls)
+38.6%
stock +39% · XLV -7%
matured Jul 10, 25
▲ Overweight · 🎯$94
Price at call : $85.27 — upside +10%
Today : $119.57 — upside -21%
Expected +10% · Actual +43% · Reason (≥ +15%) : ✓ Yes
🎯 on EHC : 91% (11 calls matureds) · 📊 on Health : 64.1% · +10.3% (39 calls)
+42.5%
stock +43% · XLV -8%
matured Jun 5, 25
RBC Capital 
May 22, 24
▲ Outperform · 🎯$95
Price at call : $84.55 — upside +12%
Today : $119.57 — upside -21%
Expected +12% · Actual +41% · Reason (≥ +15%) : ✓ Yes
🎯 on EHC : 86% (7 calls matureds) · 📊 on Health : 49.2% · +7.0% (195 calls)
+40.6%
stock +41% · XLV -10%
matured May 22, 25
Raymond James 
Apr 26, 24
▲ Strong Buy · 🎯$95
Price at call : $83.64 — upside +14%
Today : $119.57 — upside -21%
Expected +14% · Actual +38% · Reason (≥ +15%) : ✓ Yes
🎯 on EHC : 100% (1 call matured) · 📊 on Health : 42.1% · -4.4% (114 calls)
+37.9%
stock +38% · XLV -1%
matured Apr 26, 25
Barclays 
Apr 25, 24
▲ Overweight · 🎯$108
Price at call : $82.47 — upside +31%
Today : $119.57 — upside -10%
Expected +31% · Actual +40% · Reason (≥ +15%) : ✓ Yes
🎯 on EHC : 88% (8 calls matureds) · 📊 on Health : 47.9% · +1.6% (194 calls)
+39.8%
stock +40% · XLV -1%
matured Apr 25, 25
Mizuho 
Apr 25, 24
▲ Buy · 🎯$95
Price at call : $82.73 — upside +15%
Today : $119.57 — upside -21%
Expected +15% · Actual +37% · Reason (≥ +15%) : ✓ Yes
🎯 on EHC : 100% (2 calls matureds) · 📊 on Health : 57.1% · +12.3% (70 calls)
+37.0%
stock +37% · XLV -1%
matured Apr 25, 25
Barclays 
Mar 28, 24
▲ Overweight · 🎯$101
Price at call : $82.58 — upside +22%
Today : $119.57 — upside -16%
Expected +22% · Actual +22% · Reason (≥ +15%) : ✓ Yes
🎯 on EHC : 88% (8 calls matureds) · 📊 on Health : 47.9% · +1.6% (194 calls)
+22.0%
stock +22% · XLV -2%
matured Mar 28, 25
Barclays 
Mar 6, 24
▲ Overweight · 🎯$95
Price at call : $76.6 — upside +24%
Today : $119.57 — upside -21%
Expected +24% · Actual +30% · Reason (≥ +15%) : ✓ Yes
🎯 on EHC : 88% (8 calls matureds) · 📊 on Health : 47.9% · +1.6% (194 calls)
+30.1%
stock +30% · XLV +2%
matured Mar 6, 25
▲ Buy · 🎯$86
Price at call : $73.57 — upside +17%
Today : $119.57 — upside -28%
Expected +17% · Actual +34% · Reason (≥ +15%) : ✓ Yes
🎯 on EHC : 83% (12 calls matureds) · 📊 on Health : 58.7% · +5.8% (109 calls)
+34.1%
stock +34% · XLV +1%
matured Feb 8, 25
RBC Capital 
Feb 9, 24
▲ Outperform · 🎯$83
Price at call : $73.57 — upside +13%
Today : $119.57 — upside -31%
Expected +13% · Actual +34% · Reason (≥ +15%) : ✓ Yes
🎯 on EHC : 86% (7 calls matureds) · 📊 on Health : 49.2% · +7.0% (195 calls)
+34.1%
stock +34% · XLV +1%
matured Feb 8, 25
Mizuho 
Feb 9, 24
▲ Buy · 🎯$82
Price at call : $73.57 — upside +11%
Today : $119.57 — upside -31%
Expected +11% · Actual +34% · Reason (≥ +15%) : ✓ Yes
🎯 on EHC : 100% (2 calls matureds) · 📊 on Health : 57.1% · +12.3% (70 calls)
+34.1%
stock +34% · XLV +1%
matured Feb 8, 25
Stephens & Co. 
Jan 16, 24
▲ Overweight · 🎯$85
Price at call : $71.45 — upside +19%
Today : $119.57 — upside -29%
Expected +19% · Actual +31% · Reason (≥ +15%) : ✓ Yes
🎯 on EHC : 91% (11 calls matureds) · 📊 on Health : 64.1% · +10.3% (39 calls)
+31.0%
stock +31% · XLV +1%
matured Jan 15, 25
RBC Capital 
Sep 28, 23
▲ Outperform · 🎯$83
Price at call : $67.16 — upside +24%
Today : $119.57 — upside -31%
Expected +24% · Actual +44% · Reason (≥ +15%) : ✓ Yes
🎯 on EHC : 86% (7 calls matureds) · 📊 on Health : 49.2% · +7.0% (195 calls)
+43.9%
stock +44% · XLV +20%
matured Sep 27, 24
▲ Buy · 🎯$82
Price at call : $70.25 — upside +17%
Today : $119.57 — upside -31%
Expected +17% · Actual +28% · Reason (≥ +15%) : ✓ Yes
🎯 on EHC : 83% (12 calls matureds) · 📊 on Health : 58.7% · +5.8% (109 calls)
+27.6%
stock +28% · XLV +11%
matured Aug 2, 24
Stephens & Co. 
Jul 20, 23
▲ Overweight · 🎯$78
Price at call : $68.55 — upside +14%
Today : $119.57 — upside -35%
Expected +14% · Actual +25% · Reason (≥ +15%) : ✓ Yes
🎯 on EHC : 91% (11 calls matureds) · 📊 on Health : 64.1% · +10.3% (39 calls)
+24.5%
stock +25% · XLV +10%
matured Jul 19, 24
Stephens & Co. 
Jun 29, 23
▲ Overweight · 🎯$78
Price at call : $67.71 — upside +15%
Today : $119.57 — upside -35%
Expected +15% · Actual +26% · Reason (≥ +15%) : ✓ Yes
🎯 on EHC : 91% (11 calls matureds) · 📊 on Health : 64.1% · +10.3% (39 calls)
+26.1%
stock +26% · XLV +9%
matured Jun 28, 24
▲ Overweight · 🎯$74
Price at call : $64.28 — upside +15%
Today : $119.57 — upside -38%
Expected +15% · Actual +30% · Reason (≥ +15%) : ✓ Yes
🎯 on EHC : 91% (11 calls matureds) · 📊 on Health : 64.1% · +10.3% (39 calls)
+29.7%
stock +30% · XLV +5%
matured Apr 30, 24
▲ Buy · 🎯$75
Price at call : $61.35 — upside +22%
Today : $119.57 — upside -37%
Expected +22% · Actual +20% · Reason (≥ +15%) : ✓ Yes
🎯 on EHC : 83% (12 calls matureds) · 📊 on Health : 58.7% · +5.8% (109 calls)
+19.9%
stock +20% · XLV +9%
matured Feb 9, 24
▲ Overweight · 🎯$70
Price at call : $60.46 — upside +16%
Today : $119.57 — upside -41%
Expected +16% · Actual +21% · Reason (≥ +15%) : ✓ Yes
🎯 on EHC : 91% (11 calls matureds) · 📊 on Health : 64.1% · +10.3% (39 calls)
+21.5%
stock +21% · XLV +9%
matured Feb 8, 24
Stephens & Co. 
Oct 28, 22
▲ Overweight · 🎯$58
Price at call : $54.44 — upside +7%
Today : $119.57 — upside -51%
Expected +7% · Actual +11% · Reason (≥ +15%) : ✗ No
🎯 on EHC : 91% (11 calls matureds) · 📊 on Health : 64.1% · +10.3% (39 calls)
+11.4%
stock +11% · XLV -7%
matured Oct 28, 23
▲ Buy · 🎯$65
Price at call : $51.68 — upside +26%
Today : $119.57 — upside -46%
Expected +26% · Actual +37% · Reason (≥ +15%) : ✓ Yes
🎯 on EHC : 83% (12 calls matureds) · 📊 on Health : 58.7% · +5.8% (109 calls)
+36.6%
stock +37% · XLV +3%
matured Aug 8, 23
▲ Buy · 🎯$59.6659
Price at call : $42.94 — upside +39%
Today : $119.57 — upside -50%
Expected +39% · Actual +52% · Reason (≥ +15%) : ✓ Yes
🎯 on EHC : 83% (12 calls matureds) · 📊 on Health : 58.7% · +5.8% (109 calls)
+52.4%
stock +52% · XLV +7%
matured Jun 21, 23
Stephens & Co. 
Jun 21, 22
▲ Overweight · 🎯$58.8703
Price at call : $42.94 — upside +37%
Today : $119.57 — upside -51%
Expected +37% · Actual +52% · Reason (≥ +15%) : ✓ Yes
🎯 on EHC : 91% (11 calls matureds) · 📊 on Health : 64.1% · +10.3% (39 calls)
+52.4%
stock +52% · XLV +7%
matured Jun 21, 23
▲ Buy · 🎯$70.008
Price at call : $53.38 — upside +31%
Today : $119.57 — upside -41%
Expected +31% · Actual -12% · Reason (≥ +15%) : ✗ No
🎯 on EHC : 83% (12 calls matureds) · 📊 on Health : 58.7% · +5.8% (109 calls)
-11.9%
stock -12% · XLV -3%
matured Oct 13, 22
▲ Overweight · 🎯$79.5545
Price at call : $49.9364 — upside +59%
Today : $119.57 — upside -33%
Expected +59% · Actual +1% · Reason (≥ +15%) : ✗ No
🎯 on EHC : 91% (11 calls matureds) · 📊 on Health : 64.1% · +10.3% (39 calls)
+1.2%
stock +1% · XLV +16%
matured Mar 5, 21

Frequently asked questions

Should I buy Encompass Health stock?

This isn't buy advice. For Encompass Health, the analyst consensus is "Buy", with an average price target of $147 (+23% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (8 calls tracked on Encompass Health). We show the numbers — you decide.

Is it too late to buy Encompass Health? How high can it go?

The most bullish analyst target on Encompass Health is $155 (+30% above today's price); the average is $147. That's the upside they see. Check how reliable those analysts have actually been on Encompass Health on our site before trusting it.

Is Encompass Health still a good buy?

The most useful "opinion" isn't an opinion — it's a track record: 13 analysts have a real record on Encompass Health, the best hitting 100% over 8 calls. Current consensus: "Buy". Make your call on data, not noise.

What has Encompass Health's past performance been?

Historical returns and a "how much if I had invested" calculator: EHC performance & returns.

Does Encompass Health pay a dividend?

Yield, consistency and growth history of the dividend: EHC's dividend.

What is the best month to buy EHC?

The 12 months ranked by the stock's past returns: best & worst month to buy EHC.

Other Health stocks

Go further

JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)